Vascular dementia is a neurodegenerative disorder caused by the reduction of cerebral blood flow. It shows a progressive cognitive impairment. In our previous study, we found that etidronate (ET) showed neuroprotective effects against glutamate-injured PC12 cells. Thus, in this study, we aimed to observe the effects of ET on learning and memory impairment and the related mechanism in 2-vessel occlusion (2VO) model rats. Rats were administered a permanent bilateral common carotid artery occlusion to induce vascular dementia model. Two weeks later, 2VO model rats were treated with ET (20 mg/kg/day i.p.) for 1 week. Results showed that ET improved the spatial learning and memory function in 2VO rats detected by Morris water maze experiment. A reduced long-term potentiation was also rescued by ET treatment in 2VO rats. Moreover, the long-term potentiation-related proteins, calcium/calmodulin-dependent protein kinase II (CaMKII), NMDAR 2B and PSD95 were up-regulated after treatment with ET. By testing the levels of malondialdehyde and superoxide dismutase in 2VO rats, we discovered that ET lowered oxidative stress. Furthermore, ET displayed a better anti-apoptosis ability through detecting the levels of Bcl-2 and Bax protein and terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive cells. In conclusion, ET shows neuroprotective effects on 2VO rats through rescuing spatial working memory deficits, and a possible mechanism may be related to the increased synaptic transmission and the inhibition of oxidative stress and apoptosis.
Vascular dementia (VD) is considered as a progressive cognitive impairment which is caused by the reduction of cerebral blood flow (Grantham and Geerts 2002) . It is a progressive aging-related disease (Giacobini 2004) and instances increase as the population ages. More and more old people suffer from VD. Therefore, VD urgently needs attention and treatment. At present, some drugs have been reported to be therapeutic for VD (Dai et al. 2007; Xu et al. 2012; Liu et al. 2016; Luo et al. 2016) , but none of the specific drugs can cure VD. Thus, a new effective drug needs to be found to prevent the progressive cognitive and memory impairment caused by VD.
In human brain, learning and memory can be affected by many signal pathways. Calcium (Ca 2+ ) acts as a cellular second messenger and plays an extremely important role in promoting synaptic transmission (Sato et al. 2003) . Calcium/ calmodulin-dependent protein kinase II (CaMKII) is a major calcium activated protein, which interacts with a large number of synaptic proteins, such as glutamate receptor NMDAR 2B. Phosphorylated CaMKII promotes synaptic transmission in turn to increase learning and memory ability (Lisman et al. 2002; Wang et al. 2013) . Some research indicates that the level of phosphorylated CaMKII is lower in VD rats (Chao-Liang et al. 2015) , thus we need to seek a drug to enhance the level of phosphorylated CaMKII.
Disodium etidronate (ET) is the first generation of bisphosphonates used to treat osteoporosis and other bone diseases. It has a better intercellular Ca 2+ binding affinity. In our previous study, we proved for the first time that ET regulated the concentration of Ca 2+ inside and outside cells, and it reduced the reactive oxygen species generation and cell apoptosis in glutamate-injured PC12 cells . In this study, we thus hypothesized that ET would have excellent effects on learning and memory impairment in 2-vessel occlusion (2VO) model rats. And the molecular mechanisms may be involved in the activation of Ca 2+ channels associated with the increased expression of NMDAR 2B and PSD95. Meanwhile, ET can suppress excessive oxidative stress so as to reduce the incidence of neuronal apoptosis in hippocampus. Our aim is to reveal that ET can be considered a valid neuroprotective drug to treat vascular dementia.
Materials and methods
Materials and reagents ET (purity>98%) was purchased from TOKYO CHEMICAL INDUSTRY CO, LTD. (Tokyo, Japan). Anti-b-actin, anti-NMDAR2B antibody, anti-PSD95 antibody, anti-CaMKII (phospho) antibody, anti-CaMKII antibody,anti-Bax antibody, and Bcl-2 antibody were acquired from Abcam (Cambridge, UK). Superoxide Dismutase (SOD) assay kit, lipid peroxidation malondialdehyde (MDA) assay kit, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) apoptosis assay kits were purchased from Beyotime Institute of Biotechnology (Shanghai, China).
Animals
Adult male Wistar rats (200-220 g) were acquired from the Experiment Animal Center of Chinese Academy of Medical Science. Rats were raised in Animal House of Medical School of Nankai University and were housed in cages of the appropriate size with access to food and water. Prior to surgery, they had 3 days to acclimatize to new environment, which was controlled at 22 AE 2°C temperature, 50-60% humidity and under a 12-h artificial light-dark cycle. Every attempt was made to keep animal numbers and suffering to a minimum. All animal experiments were authorized by the Committee for Animal Care at Nankai University and coincided with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals.
The 2-vessel occlusion model and ET treatment Rats were divided into three groups at random (n = 6 rats/group): sham group, 2VO group, and 2VO+ET group. Rats were in abrosia but had free access to water for 12 h before surgery and operations were performed under sterile conditions. They were anesthetized by an intraperitoneal injection (i.p.) of 10% chloral hydrate (4 mL/kg), and then were fixed on the rat boards. The VD model was conducted by permanent bilateral common carotid artery occlusion and the procedure of 2-VO as described elsewhere but with small modifications (Yang et al. 2014) . The sham group received the surgery without handling the bilateral common carotid arteries. After the operation, every rat was put on an electric blanket in a sawdust cage to maintain its body core temperature between 36 and 37°C until regaining consciousness, and then they were reared in the Animal House, with food and water available to them. The 2VO+ET group: 2 weeks after 2-VO surgery, rats were treated with ET (20 mg/kg/day i.p.) dissolved in saline (Kawabata et al. 2006) . In sham and 2VO group, rats were injected the same dosage of saline intraperitoneally once daily. The treatment lasted seven consecutive days.
Morris water maze test
After 7 days of treatment, each group of rats were trained and tested in a Morris water maze (MWM, RB-100A type, Beijing Sunny Instruments Co. Ltd., Beijing, China) in order to evaluate spatial learning and memory. This equipment consisted of a circular vat (150 cm in diameter, 50 cm in height), a circular platform (10 cm in diameter, 30 cm in height), and a set of photographic devices, which could record the swimming trajectory of rats. The vat, divided into four quadrants (I-IV), was filled with water, which was maintained at 25°C and dyed by non-toxic black ink to conceal the platform. The platform was placed in the middle of quadrant I and 2 cm below the water surface.
In our study, the test contained two continuous phases, the place navigation phase and the spatial probe phase. During place navigation phase, rats were trained twice per day (8-h interval and four trials once) for five consecutive days. In each round, the rats faced the pool wall and were put into water gently from the midpoint of the wall edge in random order. Then swimming trajectories, time took to find the platform (escape latency), and swimming speeds were monitored and recorded. Recording would stop automatically 2 s after rats found the platform. If a rat failed to find the platform within 60 s, we guided it to rest on the platform for 10 s, and its escape latency was recorded as 60 s. The interval between each round was more than 10 min. The spatial probe test was performed once at least 24 h after the last trial of the navigation training. In this phase, the platform was removed. Rats were put into water from the midpoint of the wall edge in quadrant IV and swam 60 s freely. The percentage of time spent in the target quadrant was recorded.
In vivo electrophysiological test
Following the MWM test, the long-term potentiation was measured by in vivo electrophysiological test. First, the rat was narcotized with 30% urethane (0.45 mL/kg, i.p.), and then positioned on a stereotaxic frame (SR-6N; Narishige, Tokyo, Japan) for surgery, and observed according to former protocols (Gao et al. 2015) . To insert a stimulating electrode and a recording electrode, a proper incision on the scalp was cut to expose the skull and drill a hole. In stereotaxic coordinates, the bipolar stimulating electrode was positioned in hippocampal Schaffer collaterals (4.2 mm posterior to bregma, 3.5 mm left to midline, 2.3-2.6 mm below the dura), and the recording electrode was implanted in the stratum radiatum of hippocampal CA1 area (3.5 mm posterior to bregma, 2.5 mm left to midline, 2.0-2.2 mm below the dura). The test stimuli were delivered to Schaffer collaterals every 30 s at an intensity, which could evoke a response of 70% of its maximum, within a range of 0.3-0.5 mA. Sampling was made under single-pulse stimulation (0.05 Hz) for 30 min as the baseline. And then a theta burst stimulation (TBS, 30 series of 12 pulses at 200 Hz) was transmitted to induce long-term potentiation (LTP). The single-pulse recording was recovered every 60 s for 60 min following TBS.
Hematoxylin/eosin staining A portion of rats were subjected to perfusion fixation of rat brain tissue through in vivo heart. Phosphate buffer saline (PBS) was infused until the fluid appeared to be clear, followed by 4% paraformaldehyde perfusion. Once brains were removed, they were immersed in paraformaldehyde at 4°C over 24 h. Afterwards, brains were dehydrated through a gradient sucrose solution and were embedded in optimal cutting temperature (OCT) compound (Sakura Finetek Japan Co. Ltd., Tokyo, Japan) for frozen section (Leica CM 1850, Leica Instruments, Wetzlar, Germany), and sectioned at 10 lm thickness. For pathological changes in hippocampal CA1 and CA3 region, the sections were stained with celestine blue and acid fuchsin. Microscopic images were taken, in which rectangular area of equal size (0.6 9 0.5 mm) were randomly chosen from three different sections of one sample, and the average was taken. Survival pyramidal cells in hippocampal CA1 and CA3 regions were counted, respectively.
Measurement of MDA levels and SOD activity
After the electrophysiological test, the hippocampus was quickly removed from brains and stored immediately at À80°C. As necessary, total proteins in hippocampus were extracted by tissue homogenate method, and protein concentrations were determined by bicinchoninic acid Protein Assay Kit (Beyotime). After that, MDA levels and SOD activity of hippocampal tissues were measured with commercial kits according to the manufacturer's instructions.
Tunnel staining and immunofluorescence staining TUNEL procedures were applied to frozen brain sections using the TUNEL Apoptosis Assay Kit, according to the manufacturer's protocol. Apoptotic cells were detected as localized bright green cells in a green background under a laser scanning confocal microscope (LSCM; Olympus FV1000, Tokyo, Japan).
For the immunofluorescence staining, the frozen brain sections were washed three times in PBS, then were incubated with 0.5% triton for 10 min at 20-25°C, followed by washing with PBS for three times, then blocked with 10% goat serum for 1 h at 20-25°C. And followed by incubation with primary antibodies (anti-PSD95: 1 : 1000) at 4°C overnight. After primary antibody incubation, sections were washed three times in PBS, followed by incubation with the 594-conjugated anti-rabbit IgG secondary antibody (1 : 1000) for 1 h at 20-25°C. After secondary antibody incubation, sections were washed three times in PBS, followed by incubation with 4 0 ,6-diamidino-2-phenylindole (DAPI) for 5 min at 20-25°C.
Then, sections were washed three times in PBS. Finally, sections were examined under a laser scanning confocal microscope (LSCM, Olympus FV1000). The fluorescent intensity was quantified randomly for three fields of one sample by Image J software (National Institutes of Health, Bethesda, MD, USA), and the average was taken.
Western blot analysis
Proteins were electrophoresed in a 8% or 13% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (spacer gel, 80 V, 30 min; separation gel, 120 V, 90 min) and then electrotransferred to polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were incubated in 5% skim milk for 1 h at normal temperature to avoid non-specific binding, and then were incubated with primary antibodies, which were diluted by 5% skim milk at 4°C overnight. After being washed with Tris-buffered saline and Tween 20, the PVDF membranes were incubated with secondary antibodies for 40 min accurately. Subsequently, the PVDF membranes were washed with Tris-buffered saline and Tween 20 again and immersed in equal parts developing fixing reagent A and B for 1 min. Protein blots were exposed by a light exposure apparatus. Equivalent protein loading was ascertained by comparison of bactin expression quantity on the same western blot assay. The optical density ratio of every investigated protein and b-actin was analyzed.
Statistical analysis
To estimate the sample size in each group, the standard deviation of the LTP level in rats subjected to permanent bilateral common carotid artery occlusion surgery was 6.5% in previous study. For our power calculation, we assumed an equal standard deviation in each group. We wanted to show a difference of 15% in the LTP level among the groups. With a = 0.05, one-sided and a power of 99%, we needed minimum six rats per group. So, we employed 18 rats in this study. For all animal experiments, rat in each group were selected by completely randomized design. And double blinding method was used for group assignment and outcome assessment. The sample size (n) of each experimental group was described in each corresponding figure legend, and all experiments were repeated at least with three times. All results were expressed as mean AE Standard Error Mean (SEM). All data analysis was executed by SPSS 22.0 (IBM Corporation, New York, USA), and cartograms were drawn by OrignPro 8.5 (OriginLab Corporation, MA, USA). The statistical differences among three groups were analyzed by oneway ANOVA and further Dunnet's multiple comparison, and were considered significant if p < 0.05.
Results
ET ameliorated spatial cognition in water maze task For the evaluating the learning and memory function of ET, the five consecutive days of training trial were performed by MWM devices (Xu et al. 2010; Hosseinzadeh et al. 2012 ).
In the place navigation phase, the escape latency was significantly higher in 2VO group compared with that of sham group (p < 0.05). These results indicated that spatial cognitive deficit existed in the 2VO group. And treatment with ET decreased the escape latency. It means that learning and memory capacity were partially recovered in 2VO+ET group (p < 0.05, Fig. 1a ). In spatial probe phase, the percentage of time in the target quadrant was evaluated to test memory. Results revealed that rats subjected to the 2VO procedure showed worse memory capacity with shorter mean time spent in the target quadrant (p < 0.05). In 2VO group treated with ET, the memory appeared significantly improved when the rats spent more time in the target quadrant (p < 0.05, Fig. 1c and d) . We also observed the swimming speed of the three groups, and the results showed no significant differences. This observation eliminated the possibility that the learning and memory capacity differences were caused by movement disorders (Fig. 1b) .
Effects of ET on the synaptic transmission of Schaffer collateral-CA1
In in vivo electrophysiological tests, recording LTP from Schaffer collaterals to CA1, was used to measure synaptic plasticity and analyze learning and memory ability. The fEPSP slopes were obviously more enhanced 1 h after a TBS than the fEPSPs baseline during the 30 min before TBS (Fig. 2a) . What's more, the fEPSP slopes were remarkably lower in the 2VO group than those in sham group. The fEPSP slopes were evidently improved in 2VO+ET group when compared with those in 2VO group (Fig. 2b) . As a result, the synaptic plasticity of rats suffering global cerebral ischemia got injury, and ET could reduce this damage.
Effects of ET on histology of the CA1 and CA3 region
Neurodegenerative pathologic findings, such as necrosis and loss of hippocampal neurons, generally appeared in rats with cerebral ischemia, so hematoxylin/eosin staining was chosen to investigate lesions of CA1 and CA3 pyramidal cells in hippocampus. Pyramidal cells in CA1 and CA3 region were distributed orderly and arranged densely in sham group. But those cells on the section from 2VO group had severe irregular and loose arrangement, with obvious karyoclasis, karyopyknosis, and neuron loss. Compared with 2VO group, there were only slight morphology changes of pyramidal cells, and survival pyramidal cells in hippocampal CA1 and CA3 regions were significantly increased in 2VO+ET group (Fig. 3) , which demonstrated that ET can reduce neuron loss.
ET reduced oxidative stress level in hippocampus Global cerebral ischemia was certified to give rise to drastic oxidative stress, which manifested as incremental lipid peroxidation and descending antioxidant enzyme activities (Safwen et al. 2015) . The level of enzymatic antioxidant activity and lipid oxidation were determined by SOD and MDA kit, respectively. Results indicated that SOD activity was dramatically dropped in the 2VO group compared to that of sham group. And in accordance with the previous results, the administration of ET can markedly increase the SOD activity in hippocampus (p < 0.01, Fig. 4a ). The result of MDA is opposite to SOD, as shown in Fig. 4(b) , MDA level was much higher in 2VO group compared with that of the sham group. The MDA concentration was decreased after treatment with ET in 2VO+ET group (p < 0.01).
ET treatments prevented apoptosis and enhanced synaptic density A TUNEL assay was performed to estimate neuronal apoptosis in hippocampus. We found that the number of TUNEL-positive cells was significantly increased in 2VO group when compared with the number in the sham group (p < 0.01). And a substantial decrease in the 2VO+ET group, suggesting that ET prevented a loss of neurons (p < 0.05, Fig. 5a ).
We performed postsynaptic density protein 95 (PSD95) immunolabeling to examine the synaptic functional recovery through ET treatment. The results showed that the lower intensity of PSD95 in the 2VO group compare to that of the sham group (p < 0.01). And a significant increase was found in the 2VO+ET group, suggesting that ET rescued the synaptic damage (p < 0.05, Fig. 5b ). Western blotting analysis ET up-regulated the phosphorylation rates of CaMKII, NMDAR 2B, and PSD95 in 2VO rats. As shown in Fig. 6(a) and (b), decreased ratios of p-CaMKII/CaMKII, NMDAR 2B, and PSD95 were observed in hippocampus of the 2VO rats compared to those of the sham group (p < 0.01). Administration of ET significantly up-regulated the phosphorylation rates of CaMKII, NMDAR 2B and PSD95 in 2VO rats (p < 0.01 and p < 0.05 vs. the 2VO group, respectively).
We also analyzed neuronal apoptosis, which was considered as an important pathological mechanism in the development of 2VO. As shown in Fig. 6(c) , a decrease was found in Bcl-2/Bax ratio compared with sham group (p < 0.01). And the treatment with ET significantly increased the Bcl-2/Bax ratio in 2VO rats (p < 0.01 vs. the 2VO group).
Discussion
VD is a neurodegenerative disorder that results in a progressive deficits in memory and cognitive function (Rammes 2009 ). The pathogenesis of this disease is related to the reduced synaptic transmission (Xing et al. 2016 ), the generation of reactive oxygen species (Luca et al. 2015) , and neuronal apoptosis ). In our previous study, we proved that ET has a good neuroprotective effect on glutamate-injured PC12 cells . Considering this positive effect, in this study, ET characterized as a Ca 2+ regulator was used to treat 2VO model rats, and we found that ET displayed an excellent neuroprotective effect on learning and memory in 2VO rats. This positive role may be partly realized through the Ca 2+ activated NMDAR 2B signal pathway to enhance LTP and decline reactive oxygen species generation and neuronal apoptosis.
In order to study the effects of ET, we used a method of permanent bilateral common carotid artery occlusion to create a model of VD. After 3 weeks, these animals were tested by MWM task, and they showed obvious spatial learning and memory deficits by longer escape latency and shorter time spent in the target quadrant. We also found severe nuclei shrinkage and neuron death in CA1 and CA3 pyramidal cells in hippocampus. Treatment with ET was shown to significantly ameliorate the cognitive impairment ( Fig. 1) and reduce the neuronal loss (Fig. 3) .
LTP reflects a long-lasting enhancement of synaptic transmission, which is a widely accepted index of learning and memory in the hippocampus (Mans et al. 2014; Park et al. 2014) . A typical form of LTP was induced, which required Ca 2+ influx into the dendritic spine through NMDA receptor (NMDAR), and combined with calmodulin to activate CaMKII, which underwent autophosphorylation, then phosphorylation of CaMKII phosphorylated a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors, triggering a series of reactions to produce LTP (Malenka and Nicoll 1999; Lisman et al. 2002; Dai et al. 2007) . PSD95 is a molecular partner with NMDAR, which forms a molecular complex to contribute to synaptic formation (Cho et al. 1992) . The present results showed that the LTP was impaired in 2VO rats, and which involved in a reduced phosphorylation of CaMKII and decreased level of NMDAR 2B and PSD95 protein, which were consistent with that of previous reports (Dai et al. 2007; Chao-Liang et al. 2015b) . In turn, the neuroprotective effects of ET were observed, and the result showed that ET regulated Ca 2+ entering to postsynaptic membrane by activated NMDA 2B receptor, and then phosphorylated CaMKII to enhance the LTP. The activated NMDA 2B receptors bind to PSD95 to promote synaptic transmission (Figs 2, 5a and 6a,b) .
Another interpretation of the positive effect of ET against ischemic injury is involved in oxidative stress. Excessive oxidative stress contributes to the progression of cognitive decline in VD (Luca et al. 2015) . In this study, an elevated level of MDA and a decreased SOD were found in the hippocampus of 2VO rats. Treatment with ET diminished MDA production and enhanced SOD activities (Fig. 4) . Our previous study indicates that ET inhibits excessive oxidative stress in glutamate-injured PC12 cells. Our results in this study are consistent with that of our previous data, which demonstrates that the treatment with ET remarkably reduces oxidative stress in hippocampus.
Some reasons, including excessive oxidative stress caused by neuronal apoptosis, play the main role for the cognitive dysfunction in VD. Bcl-2 and Bax are widely used to evaluate the level of apoptosis (Liu et al. 2015 (Liu et al. , 2016 . The ratio of Bcl-2/Bax is higher, and the ability of anti-apoptosis is stronger. Our current results indicated that the level of apoptosis was increased by testing the expression of Bcl-2 and Bax proteins and the TUNEL-positive neurons. Treatment with ET enhanced the ratio of Bcl-2/Bax to decrease the level of apoptosis (Figs 5b and 6c) . It was also in agreement with our previous results of in vitro experiment. In general, ET exerts a neuroprotective effect on antiapoptosis.
In conclusion, our work asserts for the first time that ET has excellent effects on learning and memory impairment in 2VO rats. Moreover, ET activates the Ca 2+ pathway and increases phosphorylation of CaMKII, expression of NMDAR 2B and PSD95. Meanwhile the inhibition of excessive oxidative stress is related with prevention of neuronal apoptosis in hippocampus (Fig. 7) . This information supports considering ET as a valid neuroprotective drug for treating VD. Fig. 7 Schematic figure illustrates the mechanism of etidronate (ET) rescuing cognitive deficits. We proposed that the molecular mechanisms of the rescued learning and memory impairment by etidronate involved in the activation of Ca 2+ channels associated with the increased expression of NMDAR 2B and PSD95. Meanwhile, it can suppress the excessive oxidative stress so as to reduce the incidence of neuronal apoptosis in hippocampus. These findings support that etidronate can be considered as a candidate neuroprotective drug with efficacy in vascular dementia.
